Rock Jack P, Scarpace Lisa, Hearshen David, Gutierrez Jorge, Fisher James L, Rosenblum Mark, Mikkelsen Tom
Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Neurosurgery. 2004 May;54(5):1111-7; discussion 1117-9. doi: 10.1227/01.neu.0000119328.56431.a7.
In patients with malignant glioma previously treated with surgery, radiation, and chemotherapy, clinical and radiographic signs of recurrent disease often require differentiation between radiation necrosis and recurrent tumor. Published work suggests that although magnetic resonance spectroscopy (MRS) can reliably differentiate pure tumor, pure necrosis, and spectroscopically normal tissues, it may not be particularly helpful because most patients have mixed histological findings comprised of necrosis and tumor. To improve our clinical ability to discriminate among these histological entities, we have analyzed MRS in conjunction with apparent diffusion coefficient (ADC) sequences derived from magnetic resonance imaging.
In 18 patients, spectroscopic and diffusion-weighted images were obtained before surgery for suspected recurrent neoplastic disease. Spectral data for pure tumor, pure necrosis, and mixed tumor and necrosis were derived from 65 spectroscopic observations in patients with previously treated gliomas (n = 16) and metastatic tumors (n = 2). Spectral data for choline (Cho), N-acetylaspartate (NAA), creatine (Cr), and lipid-lactate were analyzed separately and in conjunction with ADCs in all patients (15 observations of pure tumor, 33 observations of pure necrosis, and 13 observations of mixed tumor and necrosis). Histological specimens were obtained stereotactically at the time of surgery (<48 h after image acquisition) for recurrent disease and digitally co-registered with MRS data.
ADC values for pure tumor, pure necrosis, and mixed tumor and necrosis were 1.30, 1.60, and 1.42, respectively. Cho/NAA less than 0.20, NAA/normal Cr greater than 1.56, and NAA/Cho greater than 1.32 increase the odds that a tissue biopsy will be pure necrosis versus mixed tumor and necrosis. Although various values of all MRS ratios analyzed may provide positive correlations for histopathological differentiation of tissue between that of pure tumor and that of pure necrosis, the addition of ADC values to only NAA/Cho and NAA/normal Cr increases the odds of correct differentiation between pure tumor and pure necrosis. The addition of ADC values does not provide additional information beyond that of MRS in distinguishing specimens of mixed tumor and necrosis from either pure tumor or pure necrosis.
It has been demonstrated that MRS ratio analysis may allow for the clinical discrimination between specimens of pure tumor and pure necrosis, and the addition of ADC data into this analysis may enhance this specific differentiation. However, although a trend toward correlation between ADC values and the various histopathological features was noted, the direct addition of ADC data does not seem to allow further discrimination, beyond that provided by MRS, among specimens of mixed tumor and necrosis and either pure tumor or pure necrosis.
对于先前接受过手术、放疗和化疗的恶性胶质瘤患者,复发性疾病的临床和影像学表现常常需要鉴别是放射性坏死还是肿瘤复发。已发表的研究表明,尽管磁共振波谱(MRS)能够可靠地区分单纯肿瘤、单纯坏死以及波谱正常的组织,但它可能并非特别有用,因为大多数患者的组织学表现为坏死和肿瘤混合存在。为提高我们在这些组织学实体之间进行鉴别的临床能力,我们结合磁共振成像得出的表观扩散系数(ADC)序列对MRS进行了分析。
对18例疑似肿瘤复发的患者在手术前获取了波谱图像和扩散加权图像。单纯肿瘤、单纯坏死以及肿瘤与坏死混合的波谱数据来自于16例先前接受过治疗的胶质瘤患者和2例转移瘤患者的65次波谱观察。对所有患者(15次单纯肿瘤观察、33次单纯坏死观察以及13次肿瘤与坏死混合观察)的胆碱(Cho)、N - 乙酰天门冬氨酸(NAA)、肌酸(Cr)以及脂质 - 乳酸的波谱数据分别进行了分析,并与ADC值相结合。在手术时(图像采集后<48小时)通过立体定向获取复发性疾病的组织学标本,并将其与MRS数据进行数字配准。
单纯肿瘤、单纯坏死以及肿瘤与坏死混合的ADC值分别为1.30、1.60和1.42。Cho/NAA小于0.20、NAA/正常Cr大于1.56以及NAA/Cho大于1.32时,组织活检为单纯坏死而非肿瘤与坏死混合的可能性增加。尽管所分析的所有MRS比值的不同数值可能为单纯肿瘤和单纯坏死之间的组织病理学鉴别提供正相关关系,但仅将ADC值加入NAA/Cho和NAA/正常Cr中可增加正确区分单纯肿瘤和单纯坏死的可能性。在区分肿瘤与坏死混合标本和单纯肿瘤或单纯坏死标本时,加入ADC值并未提供超出MRS的额外信息。
已证实MRS比值分析可实现对单纯肿瘤和单纯坏死标本的临床鉴别,将ADC数据加入该分析中可能会增强这种特定的鉴别。然而,尽管注意到ADC值与各种组织病理学特征之间存在相关趋势,但直接加入ADC数据似乎并不能在MRS之外进一步区分肿瘤与坏死混合标本以及单纯肿瘤或单纯坏死标本。